Esin Şenol
- Endocrinology top 2%
- Infections and bacterial resistance 4
- Microbiology top 10%
- Molecular Medicine top 10%
-
- Antifungal resistance and susceptibility 13
- SARS-CoV-2 and COVID-19 Research 3
- COVID-19 Clinical Research Studies 3
-
- Fungal Infections and Studies 11
- Nail Diseases and Treatments 3
-
- Vaccine Coverage and Hesitancy 4
-
- Neutropenia and Cancer Infections 4
- Co-authors
- Jeffrey A. DesJardinL. BarefootDavid R. SnydmanPaul C. StarkŞahika Zeynep AkıGülsan Türköz SucakÖzlem Güzel TunçcanGonca Erbaş
- Journals
- International Journal of Infectious Diseases (2 papers)European Journal of Clinical Microbiology & Infectious Diseases (2 papers)Mycoses (2 papers)
- Partner nations
- TürkiyeUnited StatesAustralia
In The Last Decade
Esin Şenol
37 papers receiving 449 citations
Peers
Comparison fields: 5 of 90
- Endocrinology 198
- Microbiology 10
- Critical Care and Intensive Care Medicine 53
- Molecular Medicine 37
- Biological Psychiatry 14
Countries citing papers authored by Esin Şenol
This map shows the geographic impact of Esin Şenol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esin Şenol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esin Şenol more than expected).
Fields of papers citing papers by Esin Şenol
This network shows the impact of papers produced by Esin Şenol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esin Şenol. The network helps show where Esin Şenol may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Esin Şenol, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 5 | |
| 2 | 2022 | 25 | |
| 3 | 2022 | 5 | |
| 4 | 2021 | 23 | |
| 5 | 2018 | 3 | |
| 6 | 2017 | 0 | |
| 7 | 2017 | 2 | |
| 8 | 2013 | 6 | |
| 9 | 2013 | 5 | |
| 10 | Susceptibility to Teicoplanin and Daptomycin among Coagulase-Negative Staphylococci Isolated from Bloodstream Infections in Patients with Hematological Malignancies | 2011 | 1 |
| 11 | 2010 | 14 | |
| 12 | 2010 | 8 | |
| 13 | Five Years Surveillance of Nosocomial Stenotrophomonas maltophilia Infections in Gazi University Hospital | 2009 | 3 |
| 14 | 2008 | 15 | |
| 15 | 2007 | 18 | |
| 16 | 2006 | 11 | |
| 17 | 2004 | 105 | |
| 18 | 2002 | 108 | |
| 19 | 2002 | 12 | |
| 20 | 1996 | 8 |
About Esin Şenol
Esin Şenol is a scholar working on Microbiology, Infectious Diseases and Endocrinology, having authored 42 papers that have together received 460 indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (13 papers), Fungal Infections and Studies (11 papers), Vaccine Coverage and Hesitancy (4 papers), Infections and bacterial resistance (4 papers), Neutropenia and Cancer Infections (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Nail Diseases and Treatments (3 papers) and COVID-19 Clinical Research Studies (3 papers). The work is most often cited by research in Endocrinology (198 citations), Microbiology (10 citations) and Critical Care and Intensive Care Medicine (53 citations). Esin Şenol has collaborated with scholars based in Türkiye, United States and Australia. Frequent co-authors include Jeffrey A. DesJardin, L. Barefoot, David R. Snydman, Paul C. Stark, Şahika Zeynep Akı, Gülsan Türköz Sucak, Özlem Güzel Tunçcan, Gonca Erbaş, Alpay Azap and Ateş Kara. Their work appears in journals such as International Journal of Infectious Diseases, European Journal of Clinical Microbiology & Infectious Diseases, Mycoses, PLoS ONE and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.